News Image

Genelux Corporation to Participate in Fireside Chat at BTIG’s Virtual Biotechnology Conference 2024

Provided By GlobeNewswire

Last update: Jul 30, 2024

WESTLAKE VILLAGE, Calif., July 30, 2024 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced that Thomas Zindrick, President, CEO and Chairman, will discuss clinical-stage programs, recent announcements, and upcoming milestones in a fireside chat at BTIG’s Virtual Biotechnology Conference 2024.

Read more at globenewswire.com

GENELUX CORP

NASDAQ:GNLX (2/21/2025, 8:24:10 PM)

After market: 4.7 -0.11 (-2.29%)

4.81

-0.01 (-0.21%)



Find more stocks in the Stock Screener

Follow ChartMill for more